Co-administration of viscous fiber, Salba-chia and ginseng on glycemic management in type 2 diabetes: a double-blind randomized controlled trial

European Journal of Nutrition ◽

10.1007/s00394-020-02434-7 ◽

2021 ◽

Author(s):

Andreea Zurbau ◽

Lea Smircic Duvnjak ◽

Sasa Magas ◽

Elena Jovanovski ◽

Jelena Miocic ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Double Blind ◽

Randomized Controlled ◽

Glycemic Management

Download Full-text

Salba-chia (Salvia hispanica L.) in the treatment of overweight and obese patients with type 2 diabetes: A double-blind randomized controlled trial

Nutrition Metabolism and Cardiovascular Diseases ◽

10.1016/j.numecd.2016.11.124 ◽

2017 ◽

Vol 27 (2) ◽

pp. 138-146 ◽

Cited By ~ 36

Author(s):

V. Vuksan ◽

A.L. Jenkins ◽

C. Brissette ◽

L. Choleva ◽

E. Jovanovski ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Obese Patients ◽

Double Blind ◽

Salvia Hispanica ◽

Randomized Controlled ◽

Salvia Hispanica L

Download Full-text

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double‐blind randomized controlled trial ( BEGIN : ADD TO GLP ‐1 S tudy)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12661 ◽

2016 ◽

Vol 18 (7) ◽

pp. 663-670 ◽

Cited By ~ 14

Author(s):

V. R. Aroda ◽

T. S. Bailey ◽

B. Cariou ◽

S. Kumar ◽

L. A. Leiter ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Insulin Degludec ◽

Double Blind ◽

Randomized Controlled

Download Full-text

The effect of monomeric and oligomeric FLAVAnols in patients with type 2 diabetes and microalbuminuria (FLAVA-trial): a double-blind randomized controlled trial

Clinical Nutrition ◽

10.1016/j.clnu.2021.09.038 ◽

2021 ◽

Author(s):

Mardin Rashid ◽

Adrie J.M. Verhoeven ◽

Monique T. Mulder ◽

Reinier Timman ◽

Behiye Ozcan ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Controlled Trial ◽

Double Blind ◽

Randomized Controlled

Download Full-text

Dose-dependent improvement in glycemia with once-daily liraglutide without hypoglycemia or weight gain: A double-blind, randomized, controlled trial in Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2008.03.018 ◽

2008 ◽

Vol 81 (2) ◽

pp. 161-168 ◽

Cited By ~ 79

Author(s):

Y. Seino ◽

M.F. Rasmussen ◽

M. Zdravkovic ◽

K. Kaku

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Weight Gain ◽

Controlled Trial ◽

Japanese Patients ◽

Double Blind ◽

Once Daily ◽

Randomized Controlled ◽

Dose Dependent

Download Full-text

Testosterone therapy to prevent type 2 diabetes mellitus in at‐risk men (T4DM): Design and implementation of a double‐blind randomized controlled trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13601 ◽

2019 ◽

Vol 21 (4) ◽

pp. 772-780 ◽

Cited By ~ 8

Author(s):

Gary Wittert ◽

Evan Atlantis ◽

Carolyn Allan ◽

Karen Bracken ◽

Ann Conway ◽

...

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Type 2 Diabetes Mellitus ◽

Controlled Trial ◽

Testosterone Therapy ◽

Double Blind ◽

Design And Implementation ◽

Randomized Controlled

Download Full-text

Safety, tolerability and effects on cardiometabolic risk factors of empagliflozin monotherapy in drug-naïve patients with type 2 diabetes: a double-blind extension of a Phase III randomized controlled trial

Cardiovascular Diabetology ◽

10.1186/s12933-015-0314-0 ◽

2015 ◽

Vol 14 (1) ◽

Cited By ~ 56

Author(s):

Michael Roden ◽

◽

Ludwig Merker ◽

Anita Vedel Christiansen ◽

Flavien Roux ◽

...

Keyword(s):

Risk Factors ◽

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Cardiometabolic Risk ◽

Controlled Trial ◽

Phase Iii ◽

Double Blind ◽

Randomized Controlled ◽

Drug Naïve

Download Full-text

Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: A double-blind randomized controlled trial (INICOM study)

Diabetes Obesity and Metabolism ◽

10.1111/dom.12787 ◽

2016 ◽

Vol 19 (1) ◽

pp. 87-97 ◽

Cited By ~ 6

Author(s):

Soo Lim ◽

Kyung Ah Han ◽

JaeMyung Yu ◽

Parinya Chamnan ◽

Eun Sook Kim ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Combination Therapy ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Randomized Controlled ◽

Initial Combination Therapy ◽

Initial Combination

Download Full-text

Vascular function and atherosclerosis progression after 1 y of flavonoid intake in statin-treated postmenopausal women with type 2 diabetes: a double-blind randomized controlled trial

American Journal of Clinical Nutrition ◽

10.3945/ajcn.112.043745 ◽

2013 ◽

Vol 97 (5) ◽

pp. 936-942 ◽

Cited By ~ 46

Author(s):

Peter J Curtis ◽

John Potter ◽

Paul A Kroon ◽

Paddy Wilson ◽

Ketan Dhatariya ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Postmenopausal Women ◽

Vascular Function ◽

Controlled Trial ◽

Double Blind ◽

Atherosclerosis Progression ◽

Randomized Controlled ◽

Flavonoid Intake

Download Full-text

Chronic Ingestion of Flavan-3-ols and Isoflavones Improves Insulin Sensitivity and Lipoprotein Status and Attenuates Estimated 10-Year CVD Risk in Medicated Postmenopausal Women With Type 2 Diabetes: A 1-year, double-blind, randomized, controlled trial

Diabetes Care ◽

10.2337/dc11-1443 ◽

2012 ◽

Vol 35 (2) ◽

pp. 226-232 ◽

Cited By ~ 109

Author(s):

P. J. Curtis ◽

M. Sampson ◽

J. Potter ◽

K. Dhatariya ◽

P. A. Kroon ◽

...

Keyword(s):

Type 2 Diabetes ◽

Randomized Controlled Trial ◽

Insulin Sensitivity ◽

Postmenopausal Women ◽

Controlled Trial ◽

Cvd Risk ◽

Double Blind ◽

Randomized Controlled ◽

Chronic Ingestion

Download Full-text

Review of article: Chronic ingestion of flavan-3-ols and isoflavones improves insulin sensitivity and lipoprotein status and attenuates estimated 10-year cardiovascular disease risk in medicated postmenopausal women with type 2 diabetes: A 1-year, double-blind, randomized, controlled trial by Peter J. Curtis, PhD, Mike Sampson, MD, John Potter, MD, Ketan Dhatariya, MD, Paul A. Kroon, PhD, Aedin Cassidy, PhD (Diabetes Care 2012;35:226–32)

Journal of Vascular Nursing ◽

10.1016/j.jvn.2012.12.001 ◽

2013 ◽

Vol 31 (1) ◽

pp. 56

Author(s):

Lily Thomson

Keyword(s):

Type 2 Diabetes ◽

Cardiovascular Disease ◽

Randomized Controlled Trial ◽

Disease Risk ◽

Controlled Trial ◽

Cardiovascular Disease Risk ◽

Double Blind ◽

Randomized Controlled ◽

Chronic Ingestion

Download Full-text